查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1555591

病人參與解決方案市場:全球產業分析，規模，佔有率，成長，趨勢，預測，2024-2033年

Patient Engagement Solution Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份有關全球患者參與解決方案市場的詳細報告。該報告對市場推動因素、趨勢、機會和挑戰等基本市場動態進行了詳細分析，並對市場前景提供了寶貴的見解。

主要的洞察

  • 病患參與解決方案市場規模（2024 年）：213 億美元
  • 預測市場規模（2033 年）：507 億美元
  • 全球市場成長率（2024 年至 2033 年複合年增長率）：13.2%

病患參與解決方案市場 - 報告範圍

病患參與解決方案是醫療保健領域的重要進步，專注於提高病患對自身照護的參與度。這些解決方案包括各種工具和技術，旨在促進患者和醫療保健專業人員之間的溝通、加強患者教育並改善整體醫療保健結果。該市場包括患者入口網站、行動健康應用程式和遠端監控系統等平台。患者參與市場的成長是由對以患者為中心的護理的日益關注、數位醫療技術的進步以及改善醫療保健結果的需求所推動的。

推動市場成長的因素：

全球患者參與解決方案市場由幾個關鍵因素推動，包括對個人化和以患者為中心的醫療保健服務不斷增長的需求。遠距醫療、行動醫療應用和穿戴式裝置等數位醫療領域的技術進步正在提高患者參與度並推動市場擴張。對慢性病管理和預防性醫療保健的日益關注也有助於市場擴張，因為這些解決方案可以更好地監測和管理健康狀況。此外，旨在改善病患照護和結果的政府措施和醫療改革進一步推動了病患參與解決方案的採用。

市場阻礙因素：

儘管市場成長潛力巨大，但病患參與解決方案市場仍面臨資料安全、隱私保護和技術整合的挑戰。確保病患資料的安全和隱私對於維持信任和遵守 HIPAA 等法規至關重要。將患者參與解決方案與現有醫療保健系統整合既複雜又昂貴，這對醫療保健提供者來說是一個挑戰。患者群體在數位健康素養和技術取得方面的差異也可能阻礙這些解決方案的廣泛採用。

市場機會：

由於技術創新和不斷發展的醫療模式，患者參與解決方案市場提供了巨大的成長機會。將人工智慧 (AI) 和機器學習整合到患者參與平台中可以支援個人化護理和預測分析。也存在將這些解決方案擴展到服務不足和獲得醫療服務可能有限的農村地區的機會。技術提供者、醫療保健組織和付款人之間的策略合作夥伴關係可以創造新的商業模式並推動市場成長。此外，對基於價值的護理和患者滿意度的更多關注為開發創新的患者參與解決方案提供了機會。

本報告涵蓋的主要問題

  • 推動全球患者參與解決方案市場成長的關鍵因素有哪些？
  • 哪些類型的患者參與解決方案在每個地區受到關注？
  • 技術進步如何改變病患參與市場的競爭格局？
  • 誰是病患參與解決方案市場的主要參與者？ 他們採取了哪些策略來維持市場影響力？
  • 全球患者參與解決方案市場的新趨勢和未來前景是什麼？

目錄

第1章 摘要整理

第2章 市場概要

  • 市場範圍/分類
  • 市場定義/範圍/限制

第3章 主要市場趨勢

  • 影響市場的主要趨勢
  • 產品革新/開發趨勢

第4章 價格分析

  • 各解決方案的價格分析
    • 訂閱定價模式
    • 永久授權
  • 平均價格分析基準

第5章 全球病人參與解決方案市場的需求(金額:10億美元)分析

  • 市場金額(10億美元)分析，2019～2023年
  • 市場金額(10億美元)預測，2024～2033年
    • 與前一年同期比較成長趨勢分析
    • 絕對的商機

第6章 市場背景

  • 宏觀經濟要素
  • 預測要素- 相關性及影響
  • 價值鏈
  • COVID-19危機- 影響評估
  • 市場動態

第7章 病人參與解決方案的全球市場分析:各解決方案

  • 簡介/主要調查結果
  • 各解決方案市場規模(10億美元)分析，2019年～2023年
  • 各解決方案市場規模(10億美元)分析與預測，2024～2033年
    • 軟體
      • 整合的病人參與軟體
      • 獨立的軟體
        • 計劃管理軟體
        • 申請軟體
        • 安全的通訊軟體
        • 其他
    • 服務
      • 與實行整合
      • 諮詢
      • 支援和維修
  • 各解決方案市場魅力分析

第8章 病人參與解決方案的全球市場分析:各部署

  • 簡介/主要調查結果
  • 市場規模(10億美元)分析，各部署，2019年～2023年
  • 市場規模(10億美元)分析與預測，各部署，2024～2033年
    • 雲端
    • 內部部署
  • 各部署市場魅力分析

第9章 全球病人參與解決方案市場分析:各用途

  • 簡介/主要調查結果
  • 市場規模(10億美元)分析，各用途，2019年～2023年
  • 市場規模(10億美元)分析與預測，各用途，2024～2033年
    • 健康管理
    • 社群管理
    • 家庭醫療保健管理
    • 財務健全性管理
    • 其他
  • 各用途的市場魅力分析

第10章 全球病人參與解決方案市場分析:各終端用戶

  • 簡介/主要調查結果
  • 市場規模(10億美元)分析，各終端用戶，2019年～2023年
  • 市場規模(10億美元)分析與預測，各終端用戶，2024～2033年
    • 患者
    • 付款者
    • 醫療保健提供者
    • 其他
  • 各終端用戶市場魅力分析

第11章 全球病人參與解決方案市場分析:各地區

  • 簡介/主要調查結果
  • 市場規模(10億美元)分析，各地區，2019年～2023年
  • 市場規模(10億美元)分析與預測，各地區，2024～2033年
    • 北美
    • 南美
    • 歐洲
    • 東亞
    • 南亞太地區
    • 中東及非洲
  • 各地區市場的魅力分析

第12章 北美的病人參與解決方案市場分析

第13章 南美的病人參與解決方案市場分析

第14章 歐洲的病人參與解決方案市場分析

第15章 南亞及太平洋地區的病人參與解決方案市場分析

第16章 東亞的病人參與解決方案市場分析

第17章 中東及非洲的病人參與解決方案市場分析

第18章 病人參與解決方案市場的主要國家分析

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 德國
  • 義大利
  • 法國
  • 英國
  • 西班牙
  • 荷比盧三國
  • 俄羅斯
  • 其他歐洲
  • 中國
  • 日本
  • 韓國
  • 印度
  • 馬來西亞
  • 印尼
  • 新加坡
  • 澳洲和紐西蘭
  • GCC各國
  • 土耳其
  • 南非
  • 其他中東及非洲

第19章 市場結構分析

  • 各級企業市場分析
  • 主要企業的市場佔有率分析
  • 市場影響分析

第20章 競爭分析

  • 競爭儀表板
  • 競爭基準
  • 競爭詳細內容
    • Allscripts Healthcare Solutions
    • Mckesson Corporation
    • Cerner Corporation
    • Phytel Inc
    • Medecision Inc
    • Athenahealth Inc
    • Novartis
    • Roche Holding AG
    • Bayer
    • GlaxoSmithkline
    • IQVIA

第21章 所使用的前提條件與縮寫

第22章 調查手法

簡介目錄
Product Code: PMRREP4221

Persistence Market Research has recently published an extensive report on the global Patient Engagement Solution Market. This report provides an in-depth analysis of essential market dynamics, including drivers, trends, opportunities, and challenges, offering valuable insights into the market landscape.

Key Insights:

  • Patient Engagement Solution Market Size (2024E): USD 21.3 Bn
  • Projected Market Value (2033F): USD 50.7 Bn
  • Global Market Growth Rate (CAGR 2024 to 2033): 13.2%

Patient Engagement Solution Market - Report Scope:

Patient engagement solutions represent a significant advancement in healthcare, focusing on improving patient participation in their own care. These solutions encompass a range of tools and technologies designed to facilitate communication between patients and healthcare providers, enhance patient education, and improve overall healthcare outcomes. The market includes platforms such as patient portals, mobile health apps, and remote monitoring systems. The growth of the patient engagement market is driven by the increasing emphasis on patient-centered care, advancements in digital health technologies, and the need for improved healthcare outcomes.

Market Growth Drivers:

The global patient engagement solution market is driven by several key factors, including the rising demand for personalized and patient-centered healthcare services. Technological advancements in digital health, such as telemedicine, mobile health applications, and wearable devices, are enhancing patient engagement and driving market expansion. Increased focus on chronic disease management and preventive care is also contributing to market growth, as these solutions enable better monitoring and management of health conditions. Additionally, supportive government initiatives and healthcare reforms aimed at improving patient care and outcomes are further propelling the adoption of patient engagement solutions.

Market Restraints:

Despite its growth potential, the patient engagement solution market faces challenges related to data security, privacy concerns, and technological integration. Ensuring the security and privacy of patient data is crucial for maintaining trust and compliance with regulations such as HIPAA. The integration of patient engagement solutions with existing healthcare systems can be complex and costly, posing a challenge for healthcare providers. Additionally, disparities in digital health literacy and access to technology among different patient populations may hinder the widespread adoption of these solutions.

Market Opportunities:

The patient engagement solution market offers substantial growth opportunities driven by technological innovations and evolving healthcare models. The integration of artificial intelligence (AI) and machine learning into patient engagement platforms can enhance personalized care and predictive analytics. Opportunities also exist in expanding these solutions to underserved and rural areas, where access to healthcare services may be limited. Strategic partnerships between technology providers, healthcare organizations, and payers can create new business models and drive market growth. Additionally, the growing focus on value-based care and patient satisfaction presents opportunities for developing innovative patient engagement solutions.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the patient engagement solution market globally?
  • Which types of patient engagement solutions are gaining traction in different regions?
  • How are technological advancements reshaping the competitive landscape of the patient engagement market?
  • Who are the key players contributing to the patient engagement solution market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global patient engagement solution market?

Competitive Intelligence and Business Strategy:

Key players in the global patient engagement solution market, including companies such as Cerner Corporation, Allscripts Healthcare Solutions, and Medisafe, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced patient engagement tools, enhance interoperability with existing healthcare systems, and improve user experience. Collaborations with healthcare providers, technology firms, and regulatory bodies are essential to drive market adoption and address emerging needs. Additionally, a focus on data security, integration capabilities, and customer support helps to foster market growth and ensure the successful implementation of patient engagement solutions.

Key Companies Profiled:

  • Allscripts Healthcare Solutions
  • Mckesson Corporation
  • Cerner Corporation
  • Phytel Inc
  • Medecision Inc
  • Athenahealth Inc
  • Novartis
  • Roche Holding AG
  • Bayer
  • GlaxoSmithkline
  • IQVIA

Key Segments of Patient Engagement Solution Market Industry Research

By Solution:

  • Software
  • Services

By Deployment:

  • Cloud
  • On Premise

By Application:

  • Health Management
  • Social Management
  • Home Healthcare Management
  • Financial Health Management

By End User:

  • Patients
  • Payers
  • Healthcare Providers

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia Pacific
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Pricing Analysis

  • 4.1. Pricing Analysis, By Solution
    • 4.1.1. Subscription Pricing Model
    • 4.1.2. Perpetual Licensing
  • 4.2. Average Pricing Analysis Benchmark

5. Global Patient Engagement Solution Market Demand (in Value in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 5.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 5.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 5.2.1. Y-o-Y Growth Trend Analysis
    • 5.2.2. Absolute $ Opportunity Analysis

6. Market Background

  • 6.1. Macro-Economic Factors
  • 6.2. Forecast Factors - Relevance & Impact
  • 6.3. Value Chain
  • 6.4. COVID-19 Crisis - Impact Assessment
    • 6.4.1. Current Statistics
    • 6.4.2. Short-Mid-Long Term Outlook
    • 6.4.3. Likely Rebound
  • 6.5. Market Dynamics
    • 6.5.1. Drivers
    • 6.5.2. Restraints
    • 6.5.3. Opportunities

7. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, by Solution

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size (US$ Bn) Analysis By Solution, 2019-2023
  • 7.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Solution, 2024-2033
    • 7.3.1. Software
      • 7.3.1.1. Integrated Patient Engagement Software
      • 7.3.1.2. Standalone Software
        • 7.3.1.2.1. Scheduling Software
        • 7.3.1.2.2. Billing Software
        • 7.3.1.2.3. Secure Messaging Software
        • 7.3.1.2.4. Others
    • 7.3.2. Services
      • 7.3.2.1. Implementation and Integration
      • 7.3.2.2. Consulting
      • 7.3.2.3. Support and Maintenance
  • 7.4. Market Attractiveness Analysis By Solution

8. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, by Deployment

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) Analysis By Deployment, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Deployment, 2024-2033
    • 8.3.1. Cloud
    • 8.3.2. On-Premise
  • 8.4. Market Attractiveness Analysis By Deployment

9. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2024-2033
    • 9.3.1. Health Management
    • 9.3.2. Social Management
    • 9.3.3. Home Healthcare Management
    • 9.3.4. Financial Health Management
    • 9.3.5. Others
  • 9.4. Market Attractiveness Analysis By Application

10. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
    • 10.3.1. Patients
    • 10.3.2. Payers
    • 10.3.3. Healthcare Providers
    • 10.3.4. Others
  • 10.4. Market Attractiveness Analysis By End User

11. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia Pacific
    • 11.3.6. Middle East and Africa
  • 11.4. Market Attractiveness Analysis By Region

12. North America Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 12.3.1. By Solution
    • 12.3.2. By Deployment
    • 12.3.3. By Application
    • 12.3.4. By End User
    • 12.3.5. By Country
      • 12.3.5.1. U.S.
      • 12.3.5.2. Canada
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Solution
    • 12.4.2. By Deployment
    • 12.4.3. By Application
    • 12.4.4. By End User
    • 12.4.5. By Country
  • 12.5. Market Trends
  • 12.6. Key Market Participants - Intensity Mapping

13. Latin America Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 13.3.1. By Solution
    • 13.3.2. By Deployment
    • 13.3.3. By Application
    • 13.3.4. By End User
    • 13.3.5. By Country
      • 13.3.5.1. Brazil
      • 13.3.5.2. Mexico
      • 13.3.5.3. Rest of Latin America
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Solution
    • 13.4.2. By Deployment
    • 13.4.3. By Application
    • 13.4.4. By End User
    • 13.4.5. By Country

14. Europe Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 14.3.1. By Solution
    • 14.3.2. By Deployment
    • 14.3.3. By Application
    • 14.3.4. By End User
    • 14.3.5. By Country
      • 14.3.5.1. Germany
      • 14.3.5.2. Italy
      • 14.3.5.3. France
      • 14.3.5.4. U.K.
      • 14.3.5.5. Spain
      • 14.3.5.6. BENELUX
      • 14.3.5.7. Russia
      • 14.3.5.8. Rest of Europe
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Solution
    • 14.4.2. By Deployment
    • 14.4.3. By Application
    • 14.4.4. By End User
    • 14.4.5. By Country

15. South Asia & Pacific Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 15.3.1. By Solution
    • 15.3.2. By Deployment
    • 15.3.3. By Application
    • 15.3.4. By End User
    • 15.3.5. By Country
      • 15.3.5.1. India
      • 15.3.5.2. Indonesia
      • 15.3.5.3. Malaysia
      • 15.3.5.4. Singapore
      • 15.3.5.5. Australia & New Zealand
      • 15.3.5.6. Rest of South Asia and Pacific
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Solution
    • 15.4.2. By Deployment
    • 15.4.3. By Application
    • 15.4.4. By End User
    • 15.4.5. By Country

16. East Asia Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Solution
    • 16.3.2. By Deployment
    • 16.3.3. By Application
    • 16.3.4. By End User
    • 16.3.5. By Country
      • 16.3.5.1. China
      • 16.3.5.2. Japan
      • 16.3.5.3. South Korea
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Solution
    • 16.4.2. By Deployment
    • 16.4.3. By Application
    • 16.4.4. By End User
    • 16.4.5. By Country

17. Middle East and Africa Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Solution
    • 17.3.2. By Deployment
    • 17.3.3. By Application
    • 17.3.4. By End User
    • 17.3.5. By Country
      • 17.3.5.1. GCC Countries
      • 17.3.5.2. Turkey
      • 17.3.5.3. South Africa
      • 17.3.5.4. Rest of Middle East and Africa
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Solution
    • 17.4.2. By Deployment
    • 17.4.3. By Application
    • 17.4.4. By End User
    • 17.4.5. By Country

18. Key Countries Analysis- Patient Engagement Solution Market

  • 18.1. U.S. Patient Engagement Solution Market Analysis
    • 18.1.1. By Solution
    • 18.1.2. By Deployment
    • 18.1.3. By Application
    • 18.1.4. By End User
  • 18.2. Canada Patient Engagement Solution Market Analysis
    • 18.2.1. By Solution
    • 18.2.2. By Deployment
    • 18.2.3. By Application
    • 18.2.4. By End User
  • 18.3. Mexico Patient Engagement Solution Market Analysis
    • 18.3.1. By Solution
    • 18.3.2. By Deployment
    • 18.3.3. By Application
    • 18.3.4. By End User
  • 18.4. Brazil Patient Engagement Solution Market Analysis
    • 18.4.1. By Solution
    • 18.4.2. By Deployment
    • 18.4.3. By Application
    • 18.4.4. By End User
  • 18.5. Germany Patient Engagement Solution Market Analysis
    • 18.5.1. By Solution
    • 18.5.2. By Deployment
    • 18.5.3. By Application
    • 18.5.4. By End User
  • 18.6. Italy Patient Engagement Solution Market Analysis
    • 18.6.1. By Solution
    • 18.6.2. By Deployment
    • 18.6.3. By Application
    • 18.6.4. By End User
  • 18.7. France Patient Engagement Solution Market Analysis
    • 18.7.1. By Solution
    • 18.7.2. By Deployment
    • 18.7.3. By Application
    • 18.7.4. By End User
  • 18.8. U.K. Patient Engagement Solution Market Analysis
    • 18.8.1. By Solution
    • 18.8.2. By Deployment
    • 18.8.3. By Application
    • 18.8.4. By End User
  • 18.9. Spain Patient Engagement Solution Market Analysis
    • 18.9.1. By Solution
    • 18.9.2. By Deployment
    • 18.9.3. By Application
    • 18.9.4. By End User
  • 18.10. BENELUX Patient Engagement Solution Market Analysis
    • 18.10.1. By Solution
    • 18.10.2. By Deployment
    • 18.10.3. By Application
    • 18.10.4. By End User
  • 18.11. Russia Patient Engagement Solution Market Analysis
    • 18.11.1. By Solution
    • 18.11.2. By Deployment
    • 18.11.3. By Application
    • 18.11.4. By End User
  • 18.12. Rest of Europe Patient Engagement Solution Market Analysis
    • 18.12.1. By Solution
    • 18.12.2. By Deployment
    • 18.12.3. By Application
    • 18.12.4. By End User
  • 18.13. China Patient Engagement Solution Market Analysis
    • 18.13.1. By Solution
    • 18.13.2. By Deployment
    • 18.13.3. By Application
    • 18.13.4. By End User
  • 18.14. Japan Patient Engagement Solution Market Analysis
    • 18.14.1. By Solution
    • 18.14.2. By Deployment
    • 18.14.3. By Application
    • 18.14.4. By End User
  • 18.15. South Korea Patient Engagement Solution Market Analysis
    • 18.15.1. By Solution
    • 18.15.2. By Deployment
    • 18.15.3. By Application
    • 18.15.4. By End User
  • 18.16. India Patient Engagement Solution Market Analysis
    • 18.16.1. By Solution
    • 18.16.2. By Deployment
    • 18.16.3. By Application
    • 18.16.4. By End User
  • 18.17. Malaysia Patient Engagement Solution Market Analysis
    • 18.17.1. By Solution
    • 18.17.2. By Deployment
    • 18.17.3. By Application
    • 18.17.4. By End User
  • 18.18. Indonesia Patient Engagement Solution Market Analysis
    • 18.18.1. By Solution
    • 18.18.2. By Deployment
    • 18.18.3. By Application
    • 18.18.4. By End User
  • 18.19. Singapore Patient Engagement Solution Market Analysis
    • 18.19.1. By Solution
    • 18.19.2. By Deployment
    • 18.19.3. By Application
    • 18.19.4. By End User
  • 18.20. Australia and New Zealand Patient Engagement Solution Market Analysis
    • 18.20.1. By Solution
    • 18.20.2. By Deployment
    • 18.20.3. By Application
    • 18.20.4. By End User
  • 18.21. GCC Countries Patient Engagement Solution Market Analysis
    • 18.21.1. By Solution
    • 18.21.2. By Deployment
    • 18.21.3. By Application
    • 18.21.4. By End User
  • 18.22. Turkey Patient Engagement Solution Market Analysis
    • 18.22.1. By Solution
    • 18.22.2. By Deployment
    • 18.22.3. By Application
    • 18.22.4. By End User
  • 18.23. South Africa Patient Engagement Solution Market Analysis
    • 18.23.1. By Solution
    • 18.23.2. By Deployment
    • 18.23.3. By Application
    • 18.23.4. By End User
  • 18.24. Rest of Middle East and Africa Patient Engagement Solution Market Analysis
    • 18.24.1. By Solution
    • 18.24.2. By Deployment
    • 18.24.3. By Application
    • 18.24.4. By End User

19. Market Structure Analysis

  • 19.1. Market Analysis by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Benchmarking
  • 20.3. Competition Deep Dive
    • 20.3.1. Allscripts Healthcare Solutions
      • 20.3.1.1. Business Overview
      • 20.3.1.2. Product Portfolio
      • 20.3.1.3. Profitability by Market Segments (Business Segments/Region)
      • 20.3.1.4. Key Strategy & Developments
    • 20.3.2. Mckesson Corporation
      • 20.3.2.1. Business Overview
      • 20.3.2.2. Product Portfolio
      • 20.3.2.3. Profitability by Market Segments (Business Segments/Region)
      • 20.3.2.4. Key Strategy & Developments
    • 20.3.3. Cerner Corporation
      • 20.3.3.1. Business Overview
      • 20.3.3.2. Product Portfolio
      • 20.3.3.3. Profitability by Market Segments (Business Segments/Region)
      • 20.3.3.4. Key Strategy & Developments
    • 20.3.4. Phytel Inc
      • 20.3.4.1. Business Overview
      • 20.3.4.2. Product Portfolio
      • 20.3.4.3. Profitability by Market Segments (Business Segments/Region)
      • 20.3.4.4. Key Strategy & Developments
    • 20.3.5. Medecision Inc
      • 20.3.5.1. Business Overview
      • 20.3.5.2. Product Portfolio
      • 20.3.5.3. Profitability by Market Segments (Business Segments/Region)
      • 20.3.5.4. Key Strategy & Developments
    • 20.3.6. Athenahealth Inc
      • 20.3.6.1. Business Overview
      • 20.3.6.2. Product Portfolio
      • 20.3.6.3. Profitability by Market Segments (Business Segments/Region)
      • 20.3.6.4. Key Strategy & Developments
    • 20.3.7. Novartis
      • 20.3.7.1. Business Overview
      • 20.3.7.2. Product Portfolio
      • 20.3.7.3. Profitability by Market Segments (Business Segments/Region)
      • 20.3.7.4. Key Strategy & Developments
    • 20.3.8. Roche Holding AG
      • 20.3.8.1. Business Overview
      • 20.3.8.2. Product Portfolio
      • 20.3.8.3. Profitability by Market Segments (Business Segments/Region)
      • 20.3.8.4. Key Strategy & Developments
    • 20.3.9. Bayer
      • 20.3.9.1. Business Overview
      • 20.3.9.2. Product Portfolio
      • 20.3.9.3. Profitability by Market Segments (Business Segments/Region)
      • 20.3.9.4. Key Strategy & Developments
    • 20.3.10. GlaxoSmithkline
      • 20.3.10.1. Business Overview
      • 20.3.10.2. Product Portfolio
      • 20.3.10.3. Profitability by Market Segments (Business Segments/Region)
      • 20.3.10.4. Key Strategy & Developments
    • 20.3.11. IQVIA
      • 20.3.11.1. Business Overview
      • 20.3.11.2. Product Portfolio
      • 20.3.11.3. Profitability by Market Segments (Business Segments/Region)
      • 20.3.11.4. Key Strategy & Developments

21. Assumptions and Acronyms Used

22. Research Methodology